Processa Pharmaceuticals (PCSA) Return on Assets (2013 - 2026)
Processa Pharmaceuticals' (PCSA) quarterly Return on Assets came in at 0.02% in Q1 2026, up 1.0% YoY from 0.02% in Q1 2025, and down 29.68% on a QoQ basis from 0.02% in Q4 2025.
Processa Pharmaceuticals (PCSA) Return on Assets (2013 - 2026) Analysis & Trends
Processa Pharmaceuticals (PCSA) has 14 years of Return on Assets data on file, last reported at 0.02% in Q1 2026.
- Quarterly Return on Assets rose 1.0% year-over-year to 0.02% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.02% (up 1.0% YoY) and the FY2025 annual result came in at 0.0%, up 3.0% from the prior year.
- Return on Assets slipped to 0.02% in Q1 2026, from 0.02% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.0% in Q1 2022 to a low of 0.05% in Q3 2024.
- A 5-year average of 0.02% and a median of 0.02% in 2026 frame the typical range for Return on Assets.
- Annual changes were most pronounced in 2022 — Return on Assets fell 2 bps — and 2025, when it increased 3 bps.
- Tracing PCSA's Return on Assets over 5 years: stood at 0.02% in 2022, then plunged by 107 bps to 0.04% in 2023, then rose by 30 bps to 0.03% in 2024, then jumped by 38 bps to 0.02% in 2025, then fell by 30 bps to 0.02% in 2026.
- The last three Return on Assets figures came in at 0.02% (Q1 2026), 0.02% (Q4 2025), and 0.02% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.46 Bn | 78.47 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.62 Bn | 60.44 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.37 Bn | 53.24 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.43 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.27 Bn | 9.87 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.23 Bn | 26.40 Bn | - | 0.00% |
| 10 | Processa Pharmaceuticals | 5.72 Mn | 5.72 Mn | - | -0.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.02% |
| Dec 31, 2025 | -0.02% |
| Sep 30, 2025 | -0.02% |
| Jun 30, 2025 | -0.02% |
| Mar 31, 2025 | -0.03% |
| Dec 31, 2024 | -0.03% |
| Sep 30, 2024 | -0.05% |
| Jun 30, 2024 | -0.03% |
| Mar 31, 2024 | -0.04% |
| Dec 31, 2023 | -0.04% |
| Sep 30, 2023 | -0.02% |
| Jun 30, 2023 | -0.02% |
| Mar 31, 2023 | -0.03% |
| Dec 31, 2022 | -0.02% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | -0.01% |
| Jun 30, 2021 | -0.01% |